Plasma Fractionation Market
Report ID: SQMIG35H2165
Report ID: SQMIG35H2165
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35H2165 |
Region:
Global |
Published Date: August, 2025
Pages:
173
|Tables:
94
|Figures:
68
Global Plasma Fractionation Market size was valued at USD 36.2 Billion in 2024 and is poised to grow from USD 39.2 Billion in 2025 to USD 74.19 Billion by 2033, growing at a CAGR of 8.3% in the forecast period (2026–2033).
The plasma fractionation market is experiencing sustained growth, fueled by a convergence of medical, technological, and demographic factors. Plasma fractionation refers to the process of separating various plasma proteins such as immunoglobulins, albumin, and coagulation factors from donated human blood plasma. These components are critical in the treatment of a wide array of chronic and life-threatening conditions, including hemophilia, primary immunodeficiency disorders, liver diseases, and autoimmune disorders. One of the key drivers of market expansion is the rising prevalence of rare and chronic diseases, particularly among the aging global population. As the incidence of conditions requiring long-term immunoglobulin therapy grows, the demand for plasma-derived therapies has significantly increased.
The main driver of the global plasma fractionation market's growth is the world's ageing population, which is more likely to be susceptible to rare diseases that call for the usage of plasma derivatives. Additionally, the market for plasma fractionation is growing due to the increased use of immunoglobulins and alpha-1-antitrypsin in many medical fields globally.
How is AI Enhancing Efficiency in Plasma Fractionation?
Artificial intelligence (AI) is playing an increasingly transformative role in the plasma fractionation market, primarily by enhancing process efficiency, quality control, and demand forecasting across plasma collection, testing, and product manufacturing. AI technologies are being integrated into donor screening, plasma inventory management, and protein yield optimization, helping manufacturers improve operational precision, reduce costs, and ensure consistent product quality.
Market snapshot - 2026-2033
Global Market Size
USD 33.43 Billion
Largest Segment
Ethanol Precipitation
Fastest Growth
Chromatography
Growth Rate
8.3% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global plasma fractionation market is segmented into product, method, end user and region. Based on product, the market is segmented into immunoglobulins, coagulation factor concentrates, albumin, protease inhibitors and other plasma products. Based on method, the market is grouped into cryoprecipitation, chromatography, ethanol precipitation, ultrafiltration and others. Based on the end user, the market is segmented into hospitals & clinics, clinical research laboratories and academic institutes. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and Middle East & Africa.
How has Increased Plasma Donation Supported Immunoglobulin Demand?
As per global plasma fractionation market outlook, immunoglobulins are the dominant segment in the market due to their widespread use in treating neurological conditions such as chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barré syndrome. Their clinical versatility, growing applications in off-label treatments, and expanding awareness among physicians have resulted in consistent demand. The increase in plasma donation centers and production capacity has further supported their accessibility, reinforcing their top position in the market.
As per global plasma fractionation market analysis, coagulation factor concentrates are emerging as the fastest-growing segment. This growth is largely driven by the rising diagnosis and treatment of hemophilia and other bleeding disorders, supported by advancements in recombinant and plasma-derived therapies. In addition, expanding screening initiatives, better disease management programs, and a rising patient population in emerging economies have boosted demand. Newer extended half-life formulations and increasing government focus on rare disease management contribute further to segment expansion.
Why do Biopharmaceutical Companies Continue to Rely on Ethanol Precipitation?
As per global plasma fractionation market forecast, ethanol precipitation remains the most dominant technique in plasma fractionation due to its proven efficiency, scalability, and long-standing regulatory acceptance. The process, pioneered by Edwin Cohn, is still widely used for large-scale fractionation of plasma proteins like immunoglobulins, albumin, and clotting factors. Its ability to selectively precipitate proteins by adjusting ethanol concentration, pH, and temperature makes it a reliable and cost-effective method in both developed and developing regions. Major biopharmaceutical companies continue to depend on this method for its consistent yields and compatibility with validated manufacturing processes.
Chromatography is emerging as the fastest-growing technique in plasma fractionation, driven by increasing demand for higher purity, better protein recovery, and automation compatibility. It offers more precise separation of plasma components and is especially effective in purifying complex or low-abundance proteins that ethanol precipitation may not isolate effectively. Technological advancements in ion-exchange and affinity chromatography are also enabling the production of next-generation plasma-derived therapies. The growing interest in personalized medicine and niche protein therapies is further accelerating the adoption of chromatography-based fractionation systems.
To get detailed segments analysis, Request a Free Sample Report
How is the Plasma Fractionation Market Evolving in North America?
As per industry analysis, North America holds a leading position in the global plasma fractionation market, primarily driven by robust healthcare infrastructure, strong reimbursement systems, and high awareness of plasma-derived therapies. The region has a well-established network of plasma donation centers and fractionation facilities, supported by both public and private healthcare initiatives. Technological advancements and regulatory support for biology continue to fuel the market’s growth in this region.
Plasma Fractionation Market in the U.S.
The U.S. dominates the North America region due to its advanced therapeutic landscape and high volume of plasma donations. The presence of major fractionators, investment in R&D, and a growing patient base for immunological and hematological conditions are key growth factors.
Plasma Fractionation Market in Canada
Canada shows steady growth, supported by public health programs, rising adoption of immunoglobulins, and partnerships with international plasma collectors. Increased awareness about rare diseases and improved access to plasma-derived treatments is boosting the market gradually.
What Factors are Driving the Plasma Fractionation Market in Asia Pacific?
Asia Pacific is the fastest-growing region, driven by an expanding population, rising healthcare spending, and increasing diagnosis rates of rare diseases. Governments are investing in domestic plasma collection capabilities and building infrastructure for local fractionation to reduce dependency on imports.
Plasma Fractionation Market in Japan
As per regional forecast, Japan leads the region in terms of innovation and adoption of advanced biotherapies. Strong government regulation ensures safety and efficacy, while aging demographics contribute to higher demand for immunoglobulins and albumin products.
Plasma Fractionation Market in South Korea
As per regional outlook, South Korea is emerging as a biopharma hub, with investments in biologics manufacturing and increasing clinical application of plasma-derived products. The country is emphasizing local plasma collection and public-private partnerships to ensure supply chain stability.
What is Shaping the Plasma Fractionation Market in Europe?
Europe holds a significant market share due to its centralized blood plasma policies, strong regulatory frameworks, and widespread use of plasma therapies across multiple indications. Collaborative programs and pan-European plasma collection initiatives support steady growth across the continent.
Plasma Fractionation Market in Germany
Germany is a major contributor, driven by its advanced healthcare system, strong diagnostic capabilities, and presence of key market players. The country is known for high rates of plasma donation and domestic production capacity.
Plasma Fractionation Market in the U.K.
The U.K. market is shaped by growing investments in rare disease treatment and the integration of plasma therapies into public health coverage. Post-Brexit strategies include local plasma supply chain expansion and reliance on EU-aligned standards.
Plasma Fractionation Market in Italy
Italy shows promising growth supported by public awareness campaigns, improved diagnostic practices, and local production of plasma products. Collaborations with EU plasma collection programs enhance the country's supply security and therapeutic reach.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Plasma Fractionation Market Drivers
Rising Prevalence of Immunodeficiency and Bleeding Disorders
Advancements in Fractionation and Purification Technologies
Plasma Fractionation Market Restraints
Limited Plasma Collection and Supply Constraints
High Cost of Manufacturing and Regulatory Burden
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global plasma fractionation industry remains dynamic and innovation-driven, with leading players focusing on strategic collaborations, capacity expansions, and regional ecosystem development to meet the surging global demand for plasma-derived therapies. Major companies such as Grifols, Takeda, CSL Behring, and Octapharma continue to dominate the landscape by investing in new manufacturing infrastructure and expanding their plasma collection networks.
As per market strategies, in June 2024, Takeda announced the expansion of its Los Angeles plasma fractionation facility to boost production capacity for immunoglobulins and albumin, aiming to address global shortages and support rare disease treatment.
The plasma fractionation market is gradually witnessing the emergence of innovative startups that aim to transform the traditional plasma processing landscape through advanced biotechnology, AI-driven analytics, and decentralized plasma sourcing models.
Sanguina (Founded in 2019): Sanguina is pioneering an engineered red blood cell (RBC)–based platform that delivers therapeutic proteins via long-circulating RBCs. Their lead candidate, SANG‑101, is aimed at treating sickle cell disease by neutralizing abnormal hemoglobin and improving oxygen delivery. Although not traditional plasma fractionation, Sanguina’s work reflects an innovative use of plasma-derived biology and ties into the broader plasma therapy ecosystem.
Terraplasma Medical: Terraplasma Medical, established in Germany in 2016, focuses on cold atmospheric plasma devices designed to treat chronic and acute wounds. Their flagship device, “plasma care,” is a portable, battery-operated unit that uses cold plasma to inactivate pathogens (including drug-resistant bacteria), promote wound healing, and stimulate tissue regeneration. While not a fractionation company in the traditional sense, the startup leverages plasma-based biotechnology for therapeutic applications tightly aligned with the evolution of plasma-derived medical treatments.
Top Player’s Company Profiles
Recent Developments in Plasma Fractionation Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, technological advancements in fractionation processes and increased plasma collection facilities further support this expansion. Market growth is driven mainly by factors such as the growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, and the growing prevalence of respiratory diseases and AATD. However, high costs, limited reimbursements for plasma products, and market disruption caused by recombinant alternatives are expected to restrain the growth of this market to a certain extent during the forecast period.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 36.2 Billion |
| Market size value in 2033 | USD 74.19 Billion |
| Growth Rate | 8.3% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Plasma Fractionation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Plasma Fractionation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Plasma Fractionation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Plasma Fractionation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
